234 CHURCH STREET, NEW HAVEN, CT
News, Reorganization Plan
Departure of Chief Medical Officer Steven Ryder at Rallybio Corporation
Investor Presentation
Rallybio Corporation Files Certificate of Amendment for Reverse Stock Split
Reports Third Quarter 2025 Financial Results and Provides Business Updates
News
Financial Results, Press Release
Sells Interest in REV102 Program to Recursion Pharmaceuticals
Q1
FY 2025
Q3
Q2
FY 2024
RW
S-4/A
S-4
Prospectus Filed Pursuant to Rule 425
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Amended Schedule 13D - Ownership Report
Correspondence
Submission Upload
SEC Staff Correspondence